A detailed history of Harbour Investments, Inc. transactions in Invitae Corp stock. As of the latest transaction made, Harbour Investments, Inc. holds 200 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

SELL
$14.7 - $28.67 $16,625 - $32,425
-1,131 Reduced 84.97%
200 $3,000
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $7,244 - $10,012
298 Added 28.85%
1,331 $38,000
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $2,869 - $4,444
110 Added 11.92%
1,033 $35,000
Q1 2021

Aug 17, 2021

BUY
$33.06 - $56.93 $30,448 - $52,432
921 Added 46050.0%
923 $35,000
Q1 2021

May 12, 2021

BUY
$33.06 - $56.93 $66 - $113
2 New
2 $0

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.